Tobacco Use Is Associated with Increased Recurrence and Death from Gastric Cancer
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Tobacco use increases the risk of developing gastric cancer. We examined the hypothesis that gastric cancer developing in patients with a history of tobacco use may be associated with increased risk of cancer-specific death after curative surgical resection.
From the Memorial Sloan-Kettering Cancer Center Gastric Cancer prospective surgical database, we collected baseline demographic data and tumor characteristics from all patients who had undergone curative resection for gastric cancer between 1995 and 2009 and who had not received pre- or postoperative chemo- or radiotherapy. A smoking history was defined as >100 cigarettes’ lifetime use. The primary end point was gastric cancer disease-specific survival (DSS); secondary end points were 5-year disease-free survival (DFS) and overall survival (OS). Gastric cancer–specific hazard was modeled by Cox regression.
A total of 699 eligible patients were identified with a median age of 70 years (range 25–96 years); 410 (59%) were current or previous smokers. Smoking was associated with gastroesophageal junction/cardia tumors and white non-Hispanic ethnicity. Multivariate analysis included the following variables: tumor stage, age, performance status, diabetes mellitus, gender, and tumor location. In this analysis, the hazard ratio for gastric cancer DSS in smokers was 1.43 (95% confidence interval 1.08–1.91, P = 0.01). Smoking was also an independent significant risk factor for worse 5-year DFS (hazard ratio 1.46, P = 0.007) and OS (hazard ratio 1.48, P = 0.003). Among 516 patients for whom tobacco pack-year usage was available, both heavy (≥ 20 pack-years) and light (<20 pack-years) tobacco use was significantly associated with DSS, DFS, and OS.
Smoking history appears to be an independent risk factor for death from gastric cancer in patients who have undergone curative surgical resection.
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. CrossRef
- Trédaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer. 1997;72:565–73. CrossRef
- Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008;19:689–701. CrossRef
- Steevens J, Schouten LJ, Goldbohm RA, van den Brandt PA. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut. 2010;59:39–48. CrossRef
- Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165:1424–33. CrossRef
- Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21:3647–50. CrossRef
- Ramamoorthy S, Luo L, Luo E, Carethers JM. Tobacco smoking and risk of recurrence for squamous cell cancer of the anus. Cancer Detect Prev. 2008;32:116–20. CrossRef
- Aveyard P, Adab P, Cheng KK, Wallace DM, Hey K, Murphy MF. Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU Int. 2002;90:228–39. CrossRef
- Maxwell JH, Kumar B, Feng FY, et al. Tobacco use in human papillomavirus–positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res. 2010;16:1226–35. CrossRef
- Pytynia KB, Grant JR, Etzel CJ, Roberts DB, Wei Q, Sturgis EM. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol. 2004;22:3981–8. CrossRef
- Coker AL, DeSimone CP, Eggleston KS, Hopenhayn C, Nee J, Tucker T. Smoking and survival among Kentucky women diagnosed with invasive cervical cancer: 1995–2005. Gynecol Oncol. 2009;112:365–9. CrossRef
- Janjigian YY, McDonnell K, Kris MG, et al. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer. Cancer. 2010;116:670–5. CrossRef
- Rudin CM, Avila-Tang E, Harris CC, et al. Lung cancer in never smokers: molecular profiles and therapeutic implications. Clin Cancer Res. 2009;15:5646–61. CrossRef
- Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.
- World Health Organization. Guidelines for controlling and monitoring the tobacco epidemic. Geneva, Switzerland: World Health Organization; 1998.
- Smith CJ, Hansch C. The relative toxicity of compounds in mainstream cigarette smoke condensate. Food Chem Toxicol. 2000;38:637–46. CrossRef
- Dasgupta P, Rastogi S, Pillai S, et al. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest. 2006;116:2208–17. CrossRef
- Heeschen C, Jang JJ, Weis M, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med. 2001;7:833–9. CrossRef
- Gazdar AF. Environmental tobacco smoke, carcinogenesis, angiogenesis: a double whammy? Cancer Cell. 2003;4:159–60. CrossRef
- Dasgupta P, Rizwani W, Pillai S, et al. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer. 2009;124:36–45. CrossRef
- Shin VY, Jin HC, Ng EK, Sung JJ, Chu KM, Cho CH. Activation of 5-lipoxygenase is required for nicotine mediated epithelial–mesenchymal transition and tumor cell growth. Cancer Lett. 2010;292:237–45. CrossRef
- Simán JH, Forsgren A, Berglund G, Florén CH. Tobacco smoking increases the risk for gastric adenocarcinoma among Helicobacter pylori–infected individuals. Scand J Gastroenterol. 2001;36:208–13. CrossRef
- Matsuo K, Hamajima N, Ikehara Y, et al. Smoking and polymorphisms of fucosyltransferase gene Le affect success of H. pylori eradication with lansoprazole, amoxicillin, and clarithromycin. Epidemiol Infect. 2003;130:227–33. CrossRef
- Bertoni G, Sassatelli R, Nigrisoli E, et al. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol. 1996;91:258–63.
- Qiu HB, Zhang LY, Keshari RP, et al. Relationship between H. pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer. 2010;10:374. CrossRef
- Tollerud DJ, Clark JW, Brown LM, et al. Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis. 1989;139:194–8. CrossRef
- Lu LM, Zavitz CC, Chen B, Kianpour S, Wan Y, Stämpfli MR. Cigarette smoke impairs NK cell-dependent tumor immune surveillance. J Immunol. 2007;178:936–43.
- Wu AH. Exposure misclassification bias in studies of environmental tobacco smoke and lung cancer. Environ Health Perspect. 1999;107(Suppl 6):873–7. CrossRef
- Warner KE. Possible increases in the underreporting of cigarette consumption. J Am Stat Assoc. 1978;73(362):314–8.
- Wald NJ, Nanchahal K, Thompson SG, Cuckle HS. Does breathing other people’s tobacco smoke cause lung cancer? Br Med J (Clin Res Ed). 1986;293(6556):1217–22. CrossRef
- Commission on Life Science. Environmental tobacco smoke: measuring exposures and assessing health effects. Washington, DC: National Academy Press; 1986. http://www.nap.edu/catalog.php?record_id=943.
- Sung NY, Choi KS, Park EC, et al. Smoking, alcohol and gastric cancer risk in Korean men: the National Health Insurance Corporation study. Br J Cancer. 2007;97:700–4. CrossRef
- Limsui D, Vierkant RA, Tillmans LS, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010;102:1012–22. CrossRef
- Fariña-Sarasqueta A, van Lijnschoten G, Moerland E, et al. The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients. Ann Oncol. 2010;21:2396–402. CrossRef
- Ahn JB, Chung WB, Maeda O, et al. DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer. 2011;117:1847–54. CrossRef
- Meyerhardt JA, Catalano PJ, Haller DG, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003;21(3):433–40.
- Tobacco Use Is Associated with Increased Recurrence and Death from Gastric Cancer
Annals of Surgical Oncology
Volume 19, Issue 7 , pp 2088-2094
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
- 2. Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
- 3. Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
- 4. Weill Cornell Medical College, New York, NY, USA